Autonomous Surgical Robotics for Structured Procedures
#1Autonomous surgical robotics has crossed a critical proof-of-concept threshold. The 2022 STAR robot study (Johns Hopkins, published in Science Robotics) demonstrated statistically superior anastomosis consistency versus experienced human surgeons in live porcine models using a fully autonomous algorithm — no surgeon hands-on control during execution. MAKO (Stryker) already executes autonomous bone resection within surgeon-defined parameters in 500,000+ annual procedures. Activ Surgical, Caresyntax, and Moon Surgical (Maestro system) are advancing toward semi-autonomous laparoscopic task execution. The FDA's 2023 action plan for AI/ML-based Software as a Medical Device signals an accelerating regulatory pathway. The technical barriers to structured-procedure autonomy are largely solved; deployment is now gated by regulatory approval strategy, liability framework negotiation, and capital cost reduction as robotics hardware commoditizes.